Fungicides for crops: Worrying link to fungal drug resistance in UK warns scientists

Crop spraying on British farms could be aiding a life-threatening fungus suffered by tens of thousand of people in the UK each year

2014-07-15

(Press-News.org) Crop spraying on British farms could be aiding a life-threatening fungus suffered by tens of thousand of people in the UK each year.

New research by British and Dutch scientists has found that Aspergillus – a common fungus that attacks the lungs and is found in soil and other organic matter – has become resistant to life - saving drugs in parts of rural Yorkshire.

It's the first time a link has been made in the UK between drug resistance in Aspergillus and fungicide used on crops. Experts warn their findings, now published, are significant and raise serious implications for transplant patients, those with leukaemia and people who suffer from severe asthma.

In the three-year study, researchers from The University of Manchester and Radboud University, in the Netherlands, compared resistance profiles in 230 fungal samples, collected from rural areas in West Yorkshire which were treated with fungicides, to 290 air and soil samples from inner city sites across Greater Manchester.

They found no resistance from the sites in Greater Manchester compared to 1.7% resistance detected in West Yorkshire, implicating fungicide use in agriculture.

Dr Michael Bromley, Lecturer at The University of Manchester and study leader commented: "Given the frequent finding of resistance across northern Europe, it is not a surprise to see resistance in the UK. However, the clear association with triazole fungicide usage is very worrisome, as some unlucky people at risk will breathe in untreatable Aspergillus, with potentially dire consequences."

Diseases caused by Aspergillus affect millions of people worldwide, causing high morbidity and mortality. The only oral antifungal agents (triazoles) for human use are similar in structure to certain fungicides. The use of certain compounds in agriculture, notably difenoconazole, propiconazole, epoxiconazole, bromuconazole and tebuconazol are particularly likely to lead to resistance, yet are freely used in agriculture. There is a very limited range of antifungal compounds to treat fungal diseases, and some fungi are multi-resistant.

The emerging antifungal resistance in human pathogenic fungi is causing a huge threat to patients, especially to those with weaken immune systems and this study emphasises that there may be even a greater problem in treating such diseases. Previously such resistance has been observed in a few other countries (Netherlands, Denmark, Belgium, Germany, France, India, China, Iran, Tanzania and a few others) raising great concerns among clinicians. No new classes of antifungal agent are currently in clinical development.

These findings come as the Government has announced of a review of the economics of antimicrobial research. However, experts believe current practice across both health and veterinary services is failing to prevent the inappropriate prescription of antibiotics. The Science and Technology Committee has warned that the Government needs to set clear responsibilities at all levels of the NHS and veterinary medicine to achieve better stewardship of the antimicrobial drugs vital in modern medicine. INFORMATION:

ELSE PRESS RELEASES FROM THIS DATE:

Pre-diabetes label 'unhelpful and unnecessary'

2014-07-15

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota. The analysis, published in the BMJ, considered whether a diagnosis of pre-diabetes carried any health benefits such as improved diabetes prevention. The authors showed that treatments to reduce blood sugar only delayed the onset of type 2 diabetes by a few years, and found no evidence of long-term health benefits. Type 2 diabetes is typically diagnosed ...

Reduced range of facial expression indicates serious heart/lung disease

2014-07-15

Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues, finds preliminary research published online in Emergency Medicine Journal. This finding could be used to help busy emergency care doctors decide whom to prioritise for treatment, and gauge who really needs often costly and invasive tests, suggest the researchers. And it adds scientific credibility to the rapid visual assessment doctors make of how sick someone is, formally known as gestalt pretest ...

Patients with advanced co-existing illnesses and their carers face uphill struggle

2014-07-15

Patients in their last year of life with co-existing illnesses struggle to cope with a bewildering array of services and treatments, which are often poorly coordinated and lack any continuity of care, indicates an analysis of patient and carer feedback, published online in BMJ Supportive & Palliative Care. Patients and carers frequently found accessing the support they needed "impersonal" and "challenging," the comments showed. It's important to get this right, say the researchers, because 'multimorbidity,' in which patients are coping with several illnesses at the ...

Annals of Internal Medicine tip sheet for July 15, 2014, issue

2014-07-15

1. Pill appearance affects how patients take their medications* *Sound bites and b-roll footage available. See bottom of page for feed dates, times, and coordinates Heart patients significantly more likely to stop taking medication after pill changes appearance When it comes to taking generic heart medications, appearance matters, according to a study published in Annals of Internal Medicine (http://www.annals.org/article.aspx?doi=10.7326/M13-2381). Physicians often prescribe generic medications for the treatment of cardiovascular disease because generics are inexpensive ...

Changes in generic pill color and shape disrupt use

2014-07-15

Boston, MA—Generic versions of the same prescription drug are clinically interchangeable but often look different depending on the manufacturer. The FDA does not require consistent pill appearance among interchangeable generic drugs, and the shape and color of patients' pills may vary based on the particular supply at the patient's pharmacy. Studying a national cohort of patients who recently suffered a heart attack, researchers from Brigham and Women's Hospital (BWH) have found that variation in appearance of generic drugs is associated with a greater risk of patients ...

Bonuses for doctors do little to improve cancer screening in Ontario

2014-07-15

TORONTO, July 14, 2014 – Ontario spent nearly $110 million dollars between 2006 and 2010 on bonuses to motivate family doctors to screen more of their patients for cancer but these bonuses were associated with little or no improvement in actual cancer screening rates, according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study, published today in Annals of Family Medicine, tracked screening rates for cervical, breast and colorectal cancer in Ontario each year between 2000 and 2010. Researchers found no significant ...

July/August 2014 Annals of Family Medicine tip sheet

2014-07-15

High Prevalence of Unsafe All-Terrain Vehicle Ridership Among Adolescents in Iowa More youth are killed every year in the United States in all-terrain vehicle crashes than on bicycles, and since 2001, one-fifth of all ATV fatalities have involved victims aged 15 years or younger. To better understand ATV riding practices among adolescents, researchers surveyed 4,684 youths aged 11 to 16 years at 30 schools across Iowa and found the vast majority reported having ridden an ATV, and most practiced unsafe riding behaviors and had experienced at least one crash. Specifically, ...

New combination drug controls tumor growth and metastasis in mice

2014-07-15

SACRAMENTO, Calif. — Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences. "We've been studying the effects of COX and sEH inhibitors, both by themselves and in combination, for several ...

Home blood pressure-monitoring kits save insurance companies money

2014-07-14

Home blood pressure-monitoring kits can save insurance companies money by improving healthcare quality and reducing healthcare costs, according to new research in the American Heart Association's journal Hypertension. In the United States, more than 76 million adults have diagnosed high blood pressure, and many more are undiagnosed. Since high blood pressure typically has no symptoms, periodic testing is critical especially for people with the factors that put them at risk for the condition. Home monitoring kits effectively test blood pressure at regular intervals over ...

Hispanic Americans need culturally tailored heart care

2014-07-14

A first-time comprehensive overview of cardiovascular disease among Hispanics in the U.S. outlines the burden of heart disease and stroke as well as emphasizes the importance of culturally appropriate healthcare for this population. The American Heart Association scientific statement is published in the Association's journal Circulation. Hispanics represent the fastest-growing racial or ethnic population in the United States and are expected to constitute 30 percent of the total U.S. population by the year 2050. Yet, there is no comprehensive document about the cultural ...

LAST 30 PRESS RELEASES:

Model more accurately maps the impact of frost on corn crops

How did humans develop sharp vision? Lab-grown retinas show likely answer

Sour grapes? Taste, experience of sour foods depends on individual consumer

At AAAS, professor Krystal Tsosie argues the future of science must be Indigenous-led

From the lab to the living room: Decoding Parkinson’s patients movements in the real world

Research advances in porous materials, as highlighted in the 2025 Nobel Prize in Chemistry

Sally C. Morton, executive vice president of ASU Knowledge Enterprise, presents a bold and practical framework for moving research from discovery to real-world impact